Acute anaphylaxis

Active Ingredient: Epinephrine

Indication for Epinephrine

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Therapeutic intent: Curative procedure

For this indication, competent medicine agencies globally authorize below treatments:

0.05 mg repeated according to response

For:

Dosage regimens

Intravenous, 0.05 milligrams epinephrine, 1 one dose.

Detailed description

Titrate using intravenous boluses of 0.5 ml 1:10,000 solution (0.05 mg) according to response.

1 mg repeated according to response

For:

Dosage regimens

Intramuscular, 1 milligrams epinephrine, 1 one dose.

Detailed description

For intramuscular administration, a 1 mg/ml (1:1000) solution should be used.

2 mg as a single dose with the possibility of administering a second dose of 2 mg after approximately 10 minutes in the absence of clinical improvement, in case of deterioration or recurrence of symptoms

For:

Dosage regimens

In case that patient weight is ≥ 30 kg, nasal, 2 milligrams epinephrine, 1 to 2 doses in total.

Detailed description

Nasal adrenaline is indicated in the emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, foods, medicinal products and other allergens as well as idiopathic or exercise induced anaphylaxis. Treatment is indicated for adults and children with a body weight ≥30 kg.

The recommended initial dose is a single nasal administration of 2 mg adrenaline.

The patient should be advised to immediately seek emergency medical assistance for close monitoring of the anaphylactic episode and in the event further treatment is required.

In the absence of clinical improvement after approximately 10 minutes, or if deterioration occurs or symptoms reappear after the initial treatment, a second dose should be administered in the same nostril together with emergency medical help. A maximum of 4 mg (two doses) may be given unless instructed by a medical professional to give additional doses. It is recommended that patients should always carry two nasal sprays to treat an allergy emergency.

Elderly

No pharmacokinetic data are available after nasal administration of adrenaline in patients aged 65 years or older. No dose adjustment is required.

Paediatric population

The recommended posology in children with a body weight ≥30 kg is the same as adults.

The safety and efficacy of nasal adrenaline in children below 30 kg body weight has not been established. No data are available.

Dosage considerations

The patient/caregiver should be informed to seek emergency medical assistance immediately to have close monitoring of the anaphylactic episode and in the event further treatment is required.

  • If symptoms get worse or reoccur after approximately 10 minutes, or if any error in dosing is suspected, a new nasal spray should be used to give a second dose in the same nostril.
  • If a second dose is needed but not available, seek emergency medical assistance immediately.
  • Patients should preferably lie flat with feet elevated but sit up if they have breathing difficulties. Unconscious patients should be placed on their side in a recovery position.

For patients under 6 months old 0.01 mg/kg and for patients over 6 months old 0.15-0.5 mg based on the age, doses may be repeated at 5-15 minutes intervals

For:

Dosage regimens

Regimen A: In case that patient age in years is ≥ 12, intramuscular, 0.5 milligrams epinephrine, once every 5 to 15 minutes.

Regimen B: In case that patient age in years is ≥ 12, intramuscular, 0.3 milligrams epinephrine, once every 5 to 15 minutes.

Regimen C: In case that patient age in years is ≥ 6 and patient age in years is < 12, intramuscular, 0.3 milligrams epinephrine, once every 5 to 15 minutes.

Regimen D: In case that patient age in months is ≥ 6 and patient age in years is < 6, intramuscular, 0.15 milligrams epinephrine, once every 5 to 15 minutes.

Regimen E: In case that patient age in months is < 6, intramuscular, 0.01 milligrams epinephrine per kilogram of body weight, once every 5 to 15 minutes.

Detailed description

The following doses of adrenaline (epinephrine) 1 mg/ml (1:1000) solution for injection are recommended:

Age Dose
Over 12 years 0.5 mg IM (0.5ml 1mg/ml (1:1000) solution)
0.3 mg IM (0.3ml 1mg/ml (1:1000) solution) if the child is small or pre-pubertal)
6 – 12 years 0.3 mg IM (0.3ml 1mg/ml (1:1000) solution)
6 months – 6 years 0.15 mg IM (0.15ml 1mg/ml (1:1000) solution)
Under 6 months 0.01 mg/kg IM (0.01ml/kg 1mg/ml (1:1000) solution)

If necessary, these doses may be repeated several times at 5-15 minutes intervals according to blood pressure, pulse and respiratory function.

A small volume syringe should be used.

Active ingredient

Epinephrine

Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation.

Read more about Epinephrine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.